BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 729834)

  • 1. Regression of a prolactin-secreting pituitary tumor during long-term treatment with bromocriptine.
    Nillius SJ; Bergh T; Lundberg PO; Stahle J; Wide L
    Fertil Steril; 1978 Dec; 30(6):710-2. PubMed ID: 729834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of tumor reduction in hyperprolactinemic women with extrasellar macroadenomas treated with bromocriptine.
    Boulanger CM; Mashchak CA; Chang RJ
    Fertil Steril; 1985 Oct; 44(4):532-5. PubMed ID: 4054327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of pregnancy and lactation on pituitary prolactin-secreting tumours.
    Zárate A; Canales ES; Alger M; Forsbach G
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):407-12. PubMed ID: 517046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinemia. Long-term effects of bromocriptine.
    Johnston DG; Prescott RW; Kendall-Taylor P; Hall K; Crombie AL; Hall R; McGregor A; Watson MJ; Cook DB
    Am J Med; 1983 Nov; 75(5):868-74. PubMed ID: 6638052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
    Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
    Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin secreting pituitary adenoma: a review and study of their implications for fertility in women.
    Fode NC; Laws ER; Abboud CF; Randall RV; Kempers RD
    J Neurosurg Nurs; 1980 Dec; 12(4):210-3. PubMed ID: 6906361
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term medical therapy and follow-up of pediatric-adolescent patients with prolactin-secreting macroadenomas.
    Blackwell RE; Younger JB
    Fertil Steril; 1986 May; 45(5):713-6. PubMed ID: 3699173
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical course and outcome of pregnancy in twenty-five patients with pituitary microadenomas.
    Jewelewicz R; Vande Wiele RL
    Am J Obstet Gynecol; 1980 Feb; 136(3):339-43. PubMed ID: 6101517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acromegaly and galactorrhea-amenorrhea with two pituitary adenomas secreting growth hormone or prolactin. A case report.
    Tolis G; Bertrand G; Carpenter S; McKenzie JM
    Ann Intern Med; 1978 Sep; 89(3):345-8. PubMed ID: 686546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of women with amenorrhea-galactorrhea treated with bromocriptine.
    Tartagni M; Nicastri PL; Diaferia A; Di Gesù I; Loizzi P
    Clin Exp Obstet Gynecol; 1995; 22(4):301-6. PubMed ID: 8777784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.
    Goodman LA; Chang RJ
    Obstet Gynecol; 1984 Sep; 64(3 Suppl):2S-7S. PubMed ID: 6433250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bromocriptine on patients with hyperprolactinemia and amenorrhea.
    Meduri M; Deodato M; Bramanti P; Volpe A; Grasso A; Di Perri R
    Acta Neurol (Napoli); 1980 Feb; 2(1):15-22. PubMed ID: 7190350
    [No Abstract]   [Full Text] [Related]  

  • 13. Bromocriptine treatment of women with suspected pituitary prolactin-secreting microadenomas.
    Archer DF; Lattanzi DR; Moore EE; Harger JH; Herbert DL
    Am J Obstet Gynecol; 1982 Jul; 143(6):620-5. PubMed ID: 7201244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous pregnancy in women with a prolactin-producing pituitary adenoma.
    Swanson JA; Chapler FK; Sherman BM; Crickard K
    Fertil Steril; 1978 Jun; 29(6):629-31. PubMed ID: 658474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine treatment of seven women with primary amenorrhoea and prolactin-secreting pituitary tumours.
    Bergh T; Nillius SJ; Wide L
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):145-54. PubMed ID: 570900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and therapeutic modalities in women with galactorrhea.
    Turksoy RN; Farber M; Mitchell GW
    Obstet Gynecol; 1980 Sep; 56(3):323-9. PubMed ID: 6775255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persisting suppression of prolactin secretion after long-term treatment with bromocriptine in patients with prolactinomas.
    Eversmann T; Fahlbusch R; Rjosk HK; von Werder K
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):413-27. PubMed ID: 574700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cushing's disease and marked hyperprolactinemia in a patient with a pituitary macroadenoma: effectiveness of bromocriptine treatment.
    Verde G; Loli P; Berselli ME; Tagliaferri M; Dallabonzana D; Oppizzi G; Liuzzi A; Chiodini PG; Luccarelli G; Lodrini S
    J Endocrinol Invest; 1984 Feb; 7(1):51-4. PubMed ID: 6715796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prolactinoma problem.
    Reichlin S
    N Engl J Med; 1979 Feb; 300(6):313-5. PubMed ID: 759885
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic use of bromocriptine in women with amenorrhea-galactorrhea and suspected pituitary microadenoma.
    Jewelewicz R
    Adv Biochem Psychopharmacol; 1980; 23():209-15. PubMed ID: 7395612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.